The Cork hub demonstrates Alexion’s dedication to building enduring connections across IrelandAlexion, AstraZeneca Rare Disease today welcomed government officials, academic leaders, and industry partners to its hub in Cork, reinforcing the company’s commitment to productive partnerships and collaborative relationships within Ireland’s life sciences sector. Alongside established global operations in Dublin and Athlone, the Cork hub demonstrates Alexion’s dedication to building enduring connections across Ireland. Across Dublin, Athlone, and Cork, Alexion and AstraZeneca employ approximately 1,400 people in development, manufacturing, supply, and commercial roles, working together with colleagues, partners, and educational experts to advance solutions for rare disease patients. By working together, we nurture future talent and build on the region’s strengths through ongoing collaboration and shared purpose.”Michael Lohan, CEO of IDA Ireland, added: “I would like to congratulate Alexion, AstraZeneca Rare Disease on establishing its operations hub in Cork. Their presence here underscores Ireland and indeed Cork’s reputation as a key hub for the life sciences sector.